Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MARALIXIBAT vs MAVACAMTEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MARALIXIBAT vs MAVACAMTEN: Safety Overview

Metric MARALIXIBAT MAVACAMTEN
Total FAERS Reports 799 3,250
Deaths Reported 14 79
Death Rate 1.8% 2.4%
Hospitalizations 98 454
Average Patient Age 7.0 yrs 66.6 yrs
% Female Patients 42.3% 69.1%
FDA Approval Date Apr 10, 2025 Apr 28, 2022
Manufacturer Mirum Pharmaceuticals Inc. Myokardia, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription